Dioseve

About Dioseve

Dioseve Inc. operates in the biotechnology sector, focusing on reproductive health solutions. The company serves individuals and couples facing infertility issues, particularly those related to age and hereditary disorders. Dioseve's core product is the DIO Directly Induced Oocyte technology, which enables the production of a large number of fertilizable egg cells at minimal cost and in significantly less time compared to traditional methods. This technology aims to provide state-of-the-art solutions to various pregnancy-related challenges, offering novel possibilities for life creation. The business model revolves around leveraging their proprietary technology to offer fertility treatments and related services, generating revenue through direct sales and partnerships with fertility clinics and medical institutions. Dioseve's market includes both domestic and international clients, with a focus on regions with high demand for advanced fertility treatments. The company makes money by providing cutting-edge reproductive technology and services that address a critical need in the fertility market.